These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27441881)

  • 1. More New Medication Approvals.
    Turkoski BB
    Orthop Nurs; 2016; 35(4):255-8. PubMed ID: 27441881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catching Up on New Medications: New FDA Approvals.
    Turkoski BB
    Orthop Nurs; 2016; 35(1):39-42; quiz 43-4. PubMed ID: 26814007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversy still swirls around FDA user fees: since 1992, the prescription drug user fee act and reauthorizations have sped up new drug approvals--but does speed equal safety?
    Ullman K
    Ann Neurol; 2013 Nov; 74(5):A10-1. PubMed ID: 24353218
    [No Abstract]   [Full Text] [Related]  

  • 4. New FDA law will help preserve production of "life-saving" drugs.
    Thompson CA
    Am J Health Syst Pharm; 2012 Aug; 69(16):1352, 1354. PubMed ID: 22855095
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA designations for therapeutics and their impact on drug development and regulatory review outcomes.
    Kesselheim AS; Darrow JJ
    Clin Pharmacol Ther; 2015 Jan; 97(1):29-36. PubMed ID: 25670381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What's new? Medication changes 2008-2010.
    Turkoski BB
    Orthop Nurs; 2010; 29(5):344-7; quiz 348-9. PubMed ID: 20856091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription medications for use in pregnancy-perspective from the US Food and Drug Administration.
    Wesley BD; Sewell CA; Chang CY; Hatfield KP; Nguyen CP
    Am J Obstet Gynecol; 2021 Jul; 225(1):21-32. PubMed ID: 34215352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Drugs Approved in 2019.
    Ebied AM; Patel KH; Cooper-DeHoff RM
    Am J Med; 2020 Jun; 133(6):675-678. PubMed ID: 32145207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review.
    Wang B; Kesselheim AS
    BMJ; 2015 Sep; 351():h4679. PubMed ID: 26400844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications.
    DiMasi JA
    Clin Ther; 2013 Jun; 35(6):808-18. PubMed ID: 23726388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent drug approvals from the US FDA and EMEA: what the future holds.
    Pevarello P
    Future Med Chem; 2009 Apr; 1(1):35-48. PubMed ID: 21426069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
    Ostroff C; Lee CE; McMeekin J
    Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Patient-Reported Outcome Labeling in the United States (2011-2015).
    Gnanasakthy A; Mordin M; Evans E; Doward L; DeMuro C
    Value Health; 2017 Mar; 20(3):420-429. PubMed ID: 28292487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Era of faster FDA drug approval has also seen increased black-box warnings and market withdrawals.
    Frank C; Himmelstein DU; Woolhandler S; Bor DH; Wolfe SM; Heymann O; Zallman L; Lasser KE
    Health Aff (Millwood); 2014 Aug; 33(8):1453-9. PubMed ID: 25092848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA may allow more conditional drug approvals.
    J Am Vet Med Assoc; 2014 Nov; 245(9):992. PubMed ID: 25470840
    [No Abstract]   [Full Text] [Related]  

  • 16. US FDA oncology drug approvals in 2014.
    Wolford JE; Tewari KS
    Future Oncol; 2015; 11(13):1931-45. PubMed ID: 26039742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existing FDA pathways have potential to ensure early access to, and appropriate use of, specialty drugs.
    Kesselheim AS; Tan YT; Darrow JJ; Avorn J
    Health Aff (Millwood); 2014 Oct; 33(10):1770-8. PubMed ID: 25288421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2013 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2014 Feb; 13(2):85-9. PubMed ID: 24481294
    [No Abstract]   [Full Text] [Related]  

  • 19. 2015 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2016 Feb; 15(2):73-6. PubMed ID: 26837582
    [No Abstract]   [Full Text] [Related]  

  • 20. Similarities and differences in the oncology drug approval process between FDA and European Union with emphasis on in vitro companion diagnostics.
    Senderowicz AM; Pfaff O
    Clin Cancer Res; 2014 Mar; 20(6):1445-52. PubMed ID: 24634467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.